Accessible data curation and analytics for international-scale citizen science datasets

Abstract The Covid Symptom Study, a smartphone-based surveillance study on COVID-19 symptoms in the population, is an exemplar of big data citizen science. As of May 23rd, 2021, over 5 million participants have collectively logged over 360 million self-assessment reports since its introduction in Ma...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Benjamin Murray, Eric Kerfoot, Liyuan Chen, Jie Deng, Mark S. Graham, Carole H. Sudre, Erika Molteni, Liane S. Canas, Michela Antonelli, Kerstin Klaser, Alessia Visconti, Alexander Hammers, Andrew T. Chan, Paul W. Franks, Richard Davies, Jonathan Wolf, Tim D. Spector, Claire J. Steves, Marc Modat, Sebastien Ourselin
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
Q
Acceso en línea:https://doaj.org/article/4657a31169ad4964afaba25bc27b394f
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
Descripción
Sumario:Abstract The Covid Symptom Study, a smartphone-based surveillance study on COVID-19 symptoms in the population, is an exemplar of big data citizen science. As of May 23rd, 2021, over 5 million participants have collectively logged over 360 million self-assessment reports since its introduction in March 2020. The success of the Covid Symptom Study creates significant technical challenges around effective data curation. The primary issue is scale. The size of the dataset means that it can no longer be readily processed using standard Python-based data analytics software such as Pandas on commodity hardware. Alternative technologies exist but carry a higher technical complexity and are less accessible to many researchers. We present ExeTera, a Python-based open source software package designed to provide Pandas-like data analytics on datasets that approach terabyte scales. We present its design and capabilities, and show how it is a critical component of a data curation pipeline that enables reproducible research across an international research group for the Covid Symptom Study.